Clinical Trials Directory

Trials / Completed

CompletedNCT04023799

Couple User Preferences in Dual Purpose Prevention Products

Dual Purpose Prevention (DPP) Product Preferences Among Couples

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Microbicide Trials Network · Network
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

MTN-045 is a cross-sectional study that will utilize questionnaires, including Discrete-Choice Experiments (DCE) and joint decision tasks, to assess couples' preferences related to dual purpose prevention (DPP) products that could be used to prevent unintended pregnancies and HIV infection. Post-survey explanatory in-depth interviews (IDIs) will be conducted with a subset of participants to explore DPP product-related decisions..

Detailed description

MTN-045 is a cross-sectional study that will utilize questionnaires, including DCEs and joint decision tasks, and IDIs to assess heterosexual couples' preferences related to DPP products that could be used to prevent unintended pregnancies and HIV infection. One main goal of the study is to determine heterosexual couples' preferences for a DPP product to inform product delivery and future product design to maximize uptake and willingness to use among sub-Saharan African heterosexual couples. Another main goal of the study is to assess the level of influence of the male partner on a woman's preferences for a DPP product and on her decision-making process regarding product preferences and use. The MTN-045 study population will consist of approximately 400 heterosexual sub-Saharan African couples of reproductive age who have been in a relationship for ≥ 3 months and are interested in contraception and/or HIV prevention. Women who are currently using contraceptives as well as those not using contraceptives will be eligible. Couples who are living together as well as those not living together will be eligible. All participants will complete survey questionnaires, first separately from their partner, then followed by a joint couples' decision task. Up to 80 participants, i.e., one or both partners from a subset of up to 40 couples, will be selected to complete an IDI.

Conditions

Timeline

Start date
2020-01-21
Primary completion
2020-11-05
Completion
2020-11-05
First posted
2019-07-18
Last updated
2022-10-13

Locations

2 sites across 2 countries: Uganda, Zimbabwe

Source: ClinicalTrials.gov record NCT04023799. Inclusion in this directory is not an endorsement.